Cargando…
Structural Analysis of Specific Metal Chelating Inhibitor Binding to the Endonuclease Domain of Influenza pH1N1 (2009) Polymerase
It is generally recognised that novel antiviral drugs, less prone to resistance, would be a desirable alternative to current drug options in order to be able to treat potentially serious influenza infections. The viral polymerase, which performs transcription and replication of the RNA genome, is an...
Autores principales: | Kowalinski, Eva, Zubieta, Chloe, Wolkerstorfer, Andrea, Szolar, Oliver H. J., Ruigrok, Rob W. H., Cusack, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410856/ https://www.ncbi.nlm.nih.gov/pubmed/22876177 http://dx.doi.org/10.1371/journal.ppat.1002831 |
Ejemplares similares
-
Characterization of PA-N terminal domain of Influenza A polymerase reveals sequence specific RNA cleavage
por: Datta, Kausiki, et al.
Publicado: (2013) -
Host Determinant Residue Lysine 627 Lies on the Surface of a Discrete, Folded Domain of Influenza Virus Polymerase PB2 Subunit
por: Tarendeau, Franck, et al.
Publicado: (2008) -
Bunyaviridae RNA Polymerases (L-Protein) Have an N-Terminal, Influenza-Like Endonuclease Domain, Essential for Viral Cap-Dependent Transcription
por: Reguera, Juan, et al.
Publicado: (2010) -
Glycyrrhizin inhibits influenza A virus uptake into the cell
por: Wolkerstorfer, Andrea, et al.
Publicado: (2009) -
Three-dimensional model for the isolated recombinant influenza virus polymerase heterotrimer
por: Torreira, Eva, et al.
Publicado: (2007)